The Effect of Glucose Level and Diabetes Mellitus on Ctrough of Olaparib (NCT05081765) | Clinical Trial Compass
UnknownNot Applicable
The Effect of Glucose Level and Diabetes Mellitus on Ctrough of Olaparib
Poland40 participantsStarted 2021-09-20
Plain-language summary
Monitored therapy of olaparib concentrations in the blood of diabetic population probably will assess the need for individual dosing of the drug.
The project concerns on the monitored therapy of olaparib in a population of patients with DM, hyperglycemia and normal glucose level.
Currently, there are no studies assessing the effect of comorbidities and of the administered drugs on the pharmacokinetics of olaparib.
Who can participate
Age range
18 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* ovarian cancer patients treated with olaparib above than 4 days
* patient who gave permission to take part in the trial
* age \>18 years
* no history of allergy to olaparib
Exclusion Criteria:
* allergy to olaparib,
* age under 18 years,
* status of the patient which do not allowed the patient to continue the study.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
correlation between glucose level and C through.olaparib in the blood of the patients with ovarian cancer
Timeframe: through study completion, an average of 1 year